Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
AstraZeneca
Daiichi Sankyo
Express Scripts
Teva
Merck
Fuji
Cerilliant
McKinsey

Generated: April 26, 2018

DrugPatentWatch Database Preview

BILOPAQUE Drug Profile

« Back to Dashboard

Which patents cover Bilopaque, and what generic alternatives are available?

Bilopaque is a drug marketed by Ge Healthcare and is included in one NDA.

The generic ingredient in BILOPAQUE is tyropanoate sodium. There is one drug master file entry for this compound. Additional details are available on the tyropanoate sodium profile page.
Drug patent expirations by year for BILOPAQUE
Medical Subject Heading (MeSH) Categories for BILOPAQUE
Synonyms for BILOPAQUE
2-(3-(Butyrylamino)-2,4,6-triiodobenzyl)butanoic acid
2-(3-(Butyrylamino)-2,4,6-triiodobenzyl)butyric acid
2-(3-Butyramido-2,4,6-triiodbenzyl)buttersaeure, Natrium-Salz
2-[[2,4,6-triiodo-3-(1-oxobutylamino)phenyl]methyl]butanoic acid
2-[[3-(butanoylamino)-2,4,6-triiodo-phenyl]methyl]butanoic acid
2-[[3-(butanoylamino)-2,4,6-triiodophenyl]methyl]butanoic acid
2-[3-(butyrylamino)-2,4,6-triiodobenzyl]butanoic acid
2-[3-(BUTYRYLAMINO)-2,4,6-TRIIODOBENZYL]BUTYRIC ACID
27293-82-9
3-Butyramido-alpha-ethyl-2,4,6-triiodohydrocinnamic acid sodium salt
7246-21-1
AC1L1KQH
AC1LBSFG
AC1Q1VTM
AC1Q4PCM
Acidum tyropanoicum
alpha-Ethyl-beta-(2,4,6-triiodo-3-butyramidophenyl)propionic acid sodium salt
API0012761
Benzenepropanoic acid, .alpha.-ethyl-2,4, {6-triiodo-3-[(1-oxobutyl)amino]-,} monosodium salt
Benzenepropanoic acid, a-ethyl-2,4,6-triiodo-3-[(1-oxobutyl)amino]-
Benzenepropanoic acid, alpha-ethyl-2,4,6-triiodo-3-((1-oxobutyl)amino)-
Benzenepropanoic acid, alpha-ethyl-2,4,6-triiodo-3-((1-oxobutyl)amino)-, monosodium salt
Benzenepropanoic acid,4,6-triiodo-3-[(1-oxobutyl)amino]-, monosodium salt
Bilopac
Bilopaque (TN)
Bilopaque?
CAS-7246-21-1
CHEBI:135862
CHEBI:32273
CHEMBL1200899
CHEMBL1201261
CTK4F9414
D01884
D08EVN
DB09340
DR003456
DSSTox_CID_3729
DSSTox_GSID_23729
DSSTox_RID_77169
DTXSID2023729
DTXSID5048269
EINECS 230-653-9
EINECS 248-389-8
Hydrocinnamic acid, 3-butyramido-.alpha.-ethyl-2,4, 6-triiodo-, monosodium salt
Hydrocinnamic acid, 3-butyramido-.alpha.-ethyl-2,4,6-triiodo-
Hydrocinnamic acid, 3-butyramido-.alpha.-ethyl-2,4,6-triiodo-, sodium salt
Hydrocinnamic acid, 3-butyramido-alpha-ethyl-2,4,6-triiodo-, monosodium salt
Hydrocinnamic acid, 3-butyramido-alpha-ethyl-2,4,6-triiodo-, monosodium salt (8CI)
HYDROCINNAMIC ACID, 3-BUTYRAMIDO-alpha-ETHYL-2,4,6-TRIIODO-, SODIUM SALT
Hydrocinnamic acid,4,6-triiodo-, monosodium salt
LS-187166
LS-77159
Lumopaque
Natrii tyropanoas
Natrii tyropanoas [INN-Latin]
Natrium 2-(3-butyramido-2,4,6-triiodbenzyl)butyrat
Natrium tyropanoat
NCGC00181094-01
NSC-107434
NSC107434
OR077680
OR251377
OR333345
SCHEMBL104929
SCHEMBL2788021
sodium 2-[(3-butanamido-2,4,6-triiodophenyl)methyl]butanoate
sodium 2-[[3-(butanoylamino)-2,4,6-triiodophenyl]methyl]butanoate
sodium 2-[3-(butanoylamino)-2,4,6-triiodobenzyl]butanoate
sodium 2-{[3-(butanoylamino)-2,4,6-triiodophenyl]methyl}butanoate
Sodium 3-butyramido-.alpha.-ethyl-2,4,6-triiodohydrocinnamate
Sodium 3-butyramido-.alpha.-ethyl-2,6-triiodohydrocinnamate
Sodium 3-butyramido-alpha-ethyl-2,4,6-triiodohydrocinnamate
Sodium tyropanoate
Sodium tyropanoate (JAN/INN)
Sodium Tyropanoate (USAN)
Sodium-2-[(3-butanoylamino-2,4,6-triiodo-phenyl)methyl]butanoate
sodium;2-[[3-(butanoylamino)-2,4,6-triiodophenyl]methyl]butanoate
Tiropanoato sodico
Tiropanoato sodico [INN-Spanish]
Tox21_112710
TYROPANIC ACID
tyropanoate
Tyropanoate de sodium
Tyropanoate de sodium [INN-French]
Tyropanoate sodium
TYROPANOATE SODIUM (500 MG)
Tyropanoate sodium (USAN)
Tyropanoate Sodium [USAN]
Tyropanoate sodium(USAN
TYROPANOATESODIUM
Tyropanoic acid
Tyropanoic acid sodium salt
Tyropaque
WIN 8851-2
WIN-8851-2
WIN-88512

US Patents and Regulatory Information for BILOPAQUE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare BILOPAQUE tyropanoate sodium CAPSULE;ORAL 013731-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Teva
Argus Health
US Department of Justice
Citi
Farmers Insurance
Colorcon
US Army
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.